Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,488 | 625 | 99.8% |
| Education | $17.97 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,250 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,125 | 60 | $0 (2024) |
| Novo Nordisk Inc | $824.06 | 63 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $776.34 | 48 | $0 (2024) |
| Amgen Inc. | $657.84 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $541.64 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $443.26 | 29 | $0 (2024) |
| Abbott Laboratories | $360.01 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $284.77 | 32 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $264.85 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,153 | 65 | Lilly USA, LLC ($200.84) |
| 2023 | $1,207 | 69 | Lilly USA, LLC ($179.84) |
| 2022 | $780.64 | 50 | AstraZeneca Pharmaceuticals LP ($102.31) |
| 2021 | $381.12 | 22 | Insulet Corporation ($45.62) |
| 2020 | $169.55 | 12 | Novo Nordisk Inc ($23.81) |
| 2019 | $1,540 | 101 | Novo Nordisk Inc ($258.54) |
| 2018 | $2,145 | 148 | AstraZeneca Pharmaceuticals LP ($357.76) |
| 2017 | $2,130 | 161 | Lilly USA, LLC ($387.88) |
All Payment Transactions
628 individual payment records from CMS Open Payments — Page 3 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.17 | General |
| 03/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/26/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: ENDOCRINE AGENT | ||||||
| 02/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: DIABETES | ||||||
| 02/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: PSYCHIATRY | ||||||
| 02/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardio-renal | ||||||
| 01/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Bone Health | ||||||
| 01/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: PAIN | ||||||
| 01/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardiology | ||||||
| 01/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: VACCINES | ||||||
| 12/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Bone Health | ||||||
| 12/05/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: PAIN | ||||||
| 12/04/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/30/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.60 | General |
| 11/20/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Bone Health | ||||||
| 11/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,483 | 2,159 | $412,517 | $115,480 |
| 2022 | 19 | 1,494 | 2,063 | $253,108 | $102,968 |
| 2021 | 18 | 1,456 | 2,088 | $244,538 | $100,165 |
| 2020 | 18 | 1,378 | 1,982 | $215,170 | $75,554 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 233 | 415 | $150,645 | $34,885 | 23.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 237 | 237 | $88,164 | $28,300 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 212 | 328 | $83,968 | $17,056 | 20.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 91 | $46,501 | $11,503 | 24.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 68 | 68 | $5,236 | $5,131 | 98.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $7,120 | $4,507 | 63.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 314 | 584 | $4,088 | $3,994 | 97.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 73 | 75 | $2,625 | $2,129 | 81.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $6,175 | $1,983 | 32.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $5,225 | $1,681 | 32.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 85 | 153 | $3,672 | $1,442 | 39.3% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 25 | 27 | $3,564 | $862.25 | 24.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $735.00 | $595.98 | 81.1% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 11 | 11 | $539.00 | $416.24 | 77.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 39 | 41 | $1,640 | $409.11 | 24.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 24 | 24 | $1,629 | $327.81 | 20.1% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 13 | 13 | $805.00 | $188.84 | 23.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 25 | 31 | $186.00 | $68.20 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 217 | 376 | $87,232 | $30,717 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 226 | 226 | $56,048 | $27,613 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 207 | 308 | $48,664 | $15,460 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 56 | $17,416 | $6,609 | 37.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 20 | 20 | $8,900 | $5,567 | 62.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 58 | 58 | $6,960 | $3,962 | 56.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 20 | 20 | $7,140 | $3,100 | 43.4% |
About Dr. Carolyn Manhart, M.D
Dr. Carolyn Manhart, M.D is a Internal Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073619458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carolyn Manhart, M.D has received a total of $9,506 in payments from pharmaceutical and medical device companies, with $1,153 received in 2024. These payments were reported across 628 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($9,488).
As a Medicare-enrolled provider, Manhart has provided services to 5,811 Medicare beneficiaries, totaling 8,292 services with total Medicare billing of $394,166. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Omaha, NE
- Active Since 09/15/2006
- Last Updated 08/01/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073619458
Products in Payments
- FARXIGA (Drug) $503.10
- ENTRESTO (Drug) $443.26
- JARDIANCE (Drug) $415.72
- Ozempic (Drug) $333.99
- TOUJEO (Drug) $307.37
- HUMULIN (Drug) $306.83
- EVENITY (Biological) $296.90
- TRADJENTA (Drug) $284.64
- TRULICITY (Drug) $283.88
- MOUNJARO (Drug) $275.01
- Victoza (Drug) $268.27
- Kerendia (Drug) $264.85
- SYMBICORT (Drug) $236.36
- SOLIQUA (Drug) $234.75
- Prolia (Biological) $203.20
- JANUVIA (Drug) $181.00
- ELIQUIS (Drug) $166.91
- Omnipod (Device) $160.14
- BYDUREON (Drug) $152.05
- Tymlos (Biological) $131.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Omaha
Mojtaba Akhtari, M.d, M.D
Internal Medicine — Payments: $1.6M
Dr. Matthew Lunning, D.o, D.O
Internal Medicine — Payments: $650,808
Michael Dunn, M.d, M.D
Internal Medicine — Payments: $221,491
Dr. Brian Boer, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $96,162
Dr. Trevor Van Schooneveld, M.d, M.D
Internal Medicine — Payments: $91,007
Dr. Michael Schafer, Md, MD
Internal Medicine — Payments: $60,335